Even today, with still limited indications for GLP-1 use, one in eight Americans say theyve taken a GLP-1
Lower doses tend to have fewer side effects, but long-term outcomes are unknown
You should not rely on information on this website for medical, legal, or financial decisions, including, but not limited to, diagnosis and treatment of diabetes, obesity, or other conditions and circumstances where weight loss is desired
Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting
Thyroid tumors appeared in animal studies, though this hasnt been confirmed in humans
MAOIs are rarely used today but theoretically could interact with the sympathetic response to hypoglycemia